Compare AXT Inc (AXTI) vs Enveric Biosciences Inc (ENVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AXT Inc vs Enveric Biosciences Inc — how do they compare? AXT Inc trades at $80.19 (market cap $4.83B), while Enveric Biosciences Inc trades at $1.45 (market cap $6.20M). The key difference: AXT Inc is far larger — about 779× Enveric Biosciences Inc's market cap, and AXT Inc is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| AXTI | ENVB | |
|---|---|---|
Market Cap | $4.83B | $6.20M |
Sector | Technology | Health |
52-Week High | $140.83 | $17.40 |
52-Week Low | $2.05 | $1.27 |
Enterprise Value | $4.50B | $1.30M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AXT Inc
AXT develops and manufactures high-performance compound semiconductor wafer substrates. Its products, like indium phosphide and gallium arsenide, are essential for data centers, 5G, and consumer electronics.
Read more on AXTI →About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →
